- Home
- Prof Carolyn Lam
Carolyn Lam
Professor and Senior Consultant
National Heart Centre Singapore Duke-NUS, Singapore
Biography
Prof Carolyn Lam is a Senior Consultant at the Department of Cardiology and Director of Women's Heart Health at the National Heart Centre Singapore, having pioneered the first Women’s Heart Clinic in Singapore. Prof Lam is a world-renowned specialist in heart failure (particularly heart failure with preserved ejection fraction [HFpEF]). Her work in the PARAGON-HF and EMPEROR-Preserved trials led to the first FDA-approved treatment for HFpEF and the first robustly positive clinical outcomes trial in HFpEF to-date.
Featured Courses
SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure
- 1 EBAC
Published:
Learning objectives
- Recall the results of key trials in HFmrEF in different patients' sub-groups
- Describe how SGLT-2 inhibitors can be used across the range of LVEF
- Apply emerging diagnostic approaches for HFpEF and HFmrEF
- Implement best-practice strategies across the range of LVEF
Making Gains in HFpEF: An Appraisal of Where We Are Now
Published:
Learning objectives
- Identify HFpEF patients who may benefit from being initiated on an SGLT-2 inhibitor
- Recall current inertia rates amongst prescribers who manage heart failure
- Adopt effective treatment strategies for HFpEF patients early in the disease course
- Recall current guideline directed medical therapy options in HFpEF
- Review clinical, real world and quality of life evidence for the use of SGLT-2 inhibitors in HFpEF
Malaysia In Focus - ARNI Data And Its Implications On Clinical Practice
- 1.00 MMA
Published:
Learning objectives
- Understand the latest ARNI data in HFpEF and HFrEF
- Understand how emerging data relates to current practice in Malaysia
- Apply current understanding of ARNI therapy in appropriate heart failure patients